Cumberland Pharmaceuticals enters new employment agreements with five officers, including CEO at $675k salary

CUMBERLAND PHARMACEUTICALS INC

CEO A.J. Kazimi base salary set at $675,000; effective January 1, 2023.
EVP James Herman salary $310,000; VP Todd Anthony $272,500; VP Chris Bitterman $258,500; CFO John Hamm $228,000.
All agreements are at-will with no severance for cause, death, or permanent disability.
No change-in-control or termination provisions; include non-compete, non-solicitation, confidentiality covenants.
Agreements dated March 9, 2023, effective retroactively to January 1, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.